Because of government red tape and regulations and delays around creating a 'new' drug even if it's molecularly identical to an existing off-patent approved dru

Because of government red tape and regulations and delays around creating a 'new' drug even if it's molecularly identical to an existing off-patent approved drug. If a quick run in the mass spectrometer was sufficient to start selling a generic, this crap wouldn't happen. I don't understand the knee-jerk calls for more regulation when it's clear that regulation is what's allowing this unethical business model to work.